| Literature DB >> 30274505 |
Brenda Perez-Aguirre1, Uriel Soto-Barreras1, Juan Pablo Loyola-Rodriguez2, Juan Francisco Reyes-Macias3, Miguel Angel Santos-Diaz3, Alejandra Loyola-Leyva4, Obed Garcia-Cortes3.
Abstract
PURPOSE: This study aimed to determine the frequency of abnormalities in the newborn oral cavity and to evaluate the association with prenatal and perinatal factors.Entities:
Keywords: Gingival pathology; Infant; Mouth abnormalities; Newborn
Year: 2018 PMID: 30274505 PMCID: PMC6172521 DOI: 10.3345/kjp.2017.06177
Source DB: PubMed Journal: Korean J Pediatr ISSN: 1738-1061
Fig. 1.Representative image of oral inclusion cysts (arrows). (A) Bohn’s nodules. (B) Epstein’s pearls. (C) Dental lamina cysts. (D) Normal oral mucosa.
Prevalence of oral findings and genetic disorders in newborns
| Variable | Female (n=1,038) | Male (n=1,178) | Total (n=2,216) |
|---|---|---|---|
| Bohn’s nodules | 718 (69.2) | 832 (70.6) | 1,550 (70.0) |
| Epstein’s pearls | 676 (65.1) | 787 (66.8) | 1,463 (66.0) |
| Dental lamina cysts | 461 (44.4) | 530 (45.0) | 991 (44.7) |
| Odontogenic cysts | 32 (3.1) | 24 (2.03) | 56 (2.5) |
| Ankyloglossia | 16 (1.5) | 17 (1.4) | 33 (1.5) |
| Natal teeth | 4 (0.4) | 5 (0.4) | 9 (0.4) |
| Vascular malformation | 2 (0.2) | 4 (0.3) | 6 (0.3) |
| Congenital melanocytic nevi | 1 (0.1) | 0 (0) | 1 (0.1) |
| Lipoma | 1 (0.1) | 2 (0.2) | 3 (0.1) |
| Cleft lip | 1 (0.1) | 0 (0) | 1 (0.1) |
| Cleft palate | 1 (0.1) | 0 (0) | 1 (0.1) |
Values are presented as number (%).
Distribution of Bohn’s nodules and dental lamina cysts by location and sex
| Variable | Female | Male | Total |
|---|---|---|---|
| Bohn’s nodules (n=9,542) | |||
| Buccal anterior | 1,530 (43.5) | 2,092 (45.9) | 3,622 (44.8) |
| Buccal posterior | 1,920 (54.6) | 2,316 (50.8) | 4,236 (52.4) |
| Palatal anterior | 66 (1.9) | 147 (3.2) | 213 (2.6) |
| Palatal posterior | 0 (0) | 7 (0.2) | 7 (0.1) |
| Total | 3,516 (100) | 4,562 (100) | 8,078 (100) |
| Mandible | |||
| Buccal anterior | 131 (20.4) | 90 (10.9) | 180 (12.3) |
| Buccal posterior | 318 (49.6) | 416 (50.5) | 734 (50.1) |
| Lingual anterior | 90 (14.0) | 174 (21.1) | 305 (20.8) |
| Lingual posterior | 102 (15.9) | 143 (17.4) | 245 (16.8) |
| Total | 641 (100) | 823 (100) | 1,464 (100) |
| Dental lamina cysts (n=2,320) | |||
| Maxilla | |||
| Anterior | 134 (15.2) | 177 (14.3) | 311 (14.7) |
| Posterior | 750 (84.8) | 1,061 (85.7) | 1,811 (85.3) |
| Total | 884 (100) | 1,238 (100) | 2,122 (100) |
| Mandible | |||
| Anterior | 74 (80.4) | 93 (87.7) | 167 (84.3) |
| Posterior | 18 (19.6) | 13 (12.3) | 31 (15.7) |
| Total | 92 (100) | 106 (100) | 198 (100) |
Values are presented as number (%).
Maternal prenatal medical data (n=2,168)
| Variable | Number (%) |
|---|---|
| Age (yr) | |
| 14–19 | 631 (29.1) |
| 20–29 | 1,093 (50.4) |
| 30–39 | 405 (18.7) |
| >40 | 39 (1.8) |
| Systemic disease | |
| Diabetes mellitus | 22 (1.01) |
| Hypertension | 27 (1.3) |
| Hypothyroidism | 7 (0.3) |
| Epilepsy | 6 (0.3) |
| Asthma | 5 (0.2) |
| Disease occurred during pregnancy | |
| Urinary tract infection | 1,045 (48.2) |
| Yeast infection | 102 (4.7) |
| Preeclampsia | 49 (2.3) |
| Gestational diabetes mellitus | 26 (1.2) |
| Supplements prescribed during pregnancy. | |
| Folic acid | 1,629 (75.1) |
| Iron | 1,478 (68.2) |
| Calcium | 55 (2.5) |
Adjusted OR and 95% CI for the association between oral inclusion cysts in newborns and supplements prescribed during pregnancy
| Variable | Bohn’s nodules | Epstein’s pearls | Dental lamina cysts | |||
|---|---|---|---|---|---|---|
| OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | ||||
| Folic acid use | 1.79 (1.23–2.55) | 0.002[ | 1.63 (1.14–2.33) | 0.007[ | 1.45 (1.02–2.05) | 0.038[ |
| Calcium use | 1.31 (0.72–2.37) | 0.381 | 0.83 (0.49–1.41) | 0.501 | 0.85 (0.51–1.43) | 0.553 |
| Iron use | 1.05 (0.75–1.47) | 0.799 | 1.04 (0.76–1.44) | 0.794 | 0.92 (0.67–1.25) | 0.582 |
| Mother’s age <20 yr | 0.90 (0.72–1.11) | 0.317 | 0.98 (0.80–1.20) | 0.878 | 1.02 (0.84–1.25) | 0.815 |
| Mother’s age ≥40 yr | 0.79 (0.43–1.45) | 0.434 | 1.02 (0.56–1.89) | 0.926 | 0.48 (0.24–0.93) | 0.129 |
| Preeclampsia | 0.86 (0.50–1.46) | 0.561 | 0.69 (0.40–1.16) | 0.158 | 0.71 (0.41–1.22) | 0.216 |
| Urinary tract infection | 0.51 (0.20–1.29) | 0.153 | 1.57 (0.55–4.44) | 0.397 | 0.88 (0.68–1.17) | 0.245 |
| Newborn’s male sex | 1.19 (0.99–1.42) | 0.063 | 1.22 (1.03–1.46) | 0.055 | 1.12 (0.95–1.33) | 0.188 |
| Preterm birth[ | 0.63 (0.50–0.80) | <0.0001[ | 1.06 (0.83–1.35) | 0.658 | 0.86 (0.68–1.10) | 0.225 |
| Posterm birth[ | 0.63 (0.10–3.80) | 0.609 | 2.35 (0.26–8.3) | 0.448 | 1.87 (0.31–11.2) | 0.498 |
| Low birth weight[ | 0.97 (0.79–1.36) | 0.857 | 1.38 (0.94–1.88) | 0.129 | 0.82 (0.59–1.14) | 0.238 |
OR, odds ratio; CI, confidence interval.
P<0.05, statistically significant.
<37 weeks of pregnancy.
42 Weeks of pregnancy.
Birth weight less than 2,500 g.
Comparison of traits in newborns with and without oral inclusion cysts (OICs)
| Variable | Presence of OIC (n=2,021) | No presence of OIC (n=195) | |||
|---|---|---|---|---|---|
| No. (%) | Mean±SD | No. (%) | Mean±SD | ||
| Male newborns | 1,077 (53.3) | - | 101 (51.8) | - | 0.806 |
| Female newborns | 944 (46.7) | - | 94 (48.2) | - | |
| Folic acid | 1,524 (75.4) | - | 105 (53.8) | - | <0.001 |
| Iron | 1,369 (67.7) | - | 109 (55.9) | - | <0.001 |
| Calcium | 52 (2.57) | - | 3 (1.54) | - | 0.368 |
| Mother’s age (yr) | - | 24.2±6.44 | - | 24.5±6.54 | 0.574 |
| Gestational age (yr) | - | 38.9±0.150 | - | 38.6±0.125 | 0.518 |
| Birth weight (g) | - | 3099.9±455 | - | 3,072±473 | 0.639 |
| Birth length (cm) | - | 49.8±2.29 | - | 50.1±2.03 | 0.273 |
SD, standard deviation.
Chi-square test for qualitative variables and Mann Whitney U test for quantitative variables.